Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
Essent Group
ESNT
$5.41B
| $18M | ﹤0.01% |
277,457
-40,823
| -13% | -$2.53M |
2013 Q4
48 quarters
|
|
1302
Frontline
FRO
$11.7B
| $18M | ﹤0.01% |
826,343
+594,811
| +257% | +$13.9M |
2013 Q4
48 quarters
|
|
|
SOLS
1303
Solstice Advanced Materials
SOLS
$9.17B
| $18M | ﹤0.01% |
+370,015
| New | +$17.4M |
2025 Q4
0 quarters
|
|
1304
Kanzhun
BZ
$6.49B
| $18M | ﹤0.01% |
881,674
+457,324
| +108% | +$9.88M |
2022 Q1
15 quarters
|
|
1305
News Corp Class B
NWS
$17.1B
| $17.9M | ﹤0.01% |
605,762
+43,780
| +8% | +$1.31M |
2015 Q4
40 quarters
|
|
1306
Cadiz
CDZI
$324M
| $17.9M | ﹤0.01% |
3,185,700
-102,961
| -3% | -$553K |
2023 Q1
11 quarters
|
|
1307
KB Home
KBH
$2.78B
| $17.8M | ﹤0.01% |
315,249
+90,754
| +40% | +$5.58M |
2013 Q2
50 quarters
|
|
1308
PUT
Humana
HUM
$46.6B
| $17.8M | ﹤0.01% |
69,400
-141,400
| -67% | -$37.1M |
2025 Q3
1 quarter
|
|
1309
CALL
Mondelez International
MDLZ
$74.3B
| $17.8M | ﹤0.01% |
330,000
-200
| -0.1% | -$11.5K |
2025 Q2
2 quarters
|
|
1310
CALL
Lumentum
LITE
$97.4B
| $17.7M | ﹤0.01% |
48,000
-11,600
| -19% | -$2.98M |
2025 Q2
2 quarters
|
|
1311
WIX.com
WIX
$3.04B
| $17.7M | ﹤0.01% |
170,162
+70,705
| +71% | +$8.55M |
2016 Q2
38 quarters
|
|
1312
Alcoa
AA
$11.1B
| $17.6M | ﹤0.01% |
331,617
-467,396
| -58% | -$19.1M |
2013 Q2
50 quarters
|
|
1313
Watsco Inc
WSO
$12.3B
| $17.6M | ﹤0.01% |
52,285
-3,380
| -6% | -$1.21M |
2013 Q2
50 quarters
|
|
1314
Unity
U
$19.2B
| $17.6M | ﹤0.01% |
398,749
-19,490
| -5% | -$794K |
2022 Q1
15 quarters
|
|
1315
Iris Energy
IREN
$16.5B
| $17.6M | ﹤0.01% |
465,337
+435,152
| +1,442% | +$22.4M |
2025 Q2
2 quarters
|
|
1316
Cullen/Frost Bankers
CFR
$9.64B
| $17.6M | ﹤0.01% |
138,691
+30,309
| +28% | +$3.8M |
2013 Q2
50 quarters
|
|
1317
Nutanix
NTNX
$19.6B
| $17.5M | ﹤0.01% |
338,158
-19,202
| -5% | -$1.17M |
2016 Q4
36 quarters
|
|
1318
Installed Building Products
IBP
$5.13B
| $17.5M | ﹤0.01% |
67,372
+17,443
| +35% | +$4.51M |
2014 Q1
47 quarters
|
|
1319
CALL
Moderna
MRNA
$75.9B
| $17.4M | ﹤0.01% |
591,200
+419,000
| +243% | +$11.4M |
2023 Q4
8 quarters
|
|
1320
Liberty Media Corporation Series C Common Stock
FWONK
$22.9B
| $17.4M | ﹤0.01% |
176,561
+2,902
| +2% | +$285K |
2023 Q4
8 quarters
|
|
1321
Revvity
RVTY
$16.9B
| $17.4M | ﹤0.01% |
179,757
-106,012
| -37% | -$10.2M |
2013 Q2
50 quarters
|
|
1322
Reinsurance Group of America
RGA
$16.3B
| $17.4M | ﹤0.01% |
85,462
-64,202
| -43% | -$12.4M |
2013 Q2
50 quarters
|
|
|
CNH
1323
CNH Industrial
CNH
$21.7B
| $17.4M | ﹤0.01% |
1,883,894
+321,756
| +21% | +$3.21M |
2013 Q4
48 quarters
|
|
1324
Telus
TU
$12.7B
| $17.3M | ﹤0.01% |
1,316,287
+634,864
| +93% | +$8.94M |
2013 Q2
50 quarters
|
|
1325
CALL
Caterpillar
CAT
$389B
| $17.3M | ﹤0.01% |
30,200
+3,000
| +11% | +$1.67M |
2023 Q4
8 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.